Literature DB >> 9250171

X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

L H Looijenga1, A J Gillis, R J van Gurp, A J Verkerk, J W Oosterhuis.   

Abstract

In female mammalian cells, inactivation of one of the X chromosomes compensates the increased dosage of X-linked genes as compared with their male counterparts. This process is initiated by the X-inactive specific transcripts of the xist/XIST gene in cis, resulting in methylation of specific sites of genes to be silenced. However, in male germ cells, X inactivation is established by xist/XIST expression only. We investigated the X inactivation pattern in human testicular tumors of different histogenesis by analysis of XIST expression and methylation of the androgen receptor gene. XIST was expressed only in tumors derived from the germ cell lineage with supernumerical X chromosomes: seminomas, nonseminomas, and spermatocytic seminomas. Although low expression was present in testicular parenchyma with spermatogenesis, XIST was expressed at a higher level in parenchyma with carcinoma in situ, the precursor lesion of seminomas and nonseminomas. Despite the consistent expression of XIST in germ-cell-derived tumors with gain of X chromosomes, methylation of the androgen receptor gene was present in all differentiated but only in a proportion of the undifferentiated nonseminomas. This differential pattern of methylation was also found in a number of representative cell lines. Our data indicate that the counting mechanism resulting in X inactivation is functional in testicular cancers of different histogenesis. Moreover, the differentiation-dependent pattern of X inactivation as reported during normal development in the case of multiple X chromosomes by methylation is retained in these tumors. We conclude therefore that X inactivation allows the excessive gain of X chromosomes found in germ-cell-derived tumors of the adult testis. In addition, this offers an interesting model to study the fundamental mechanisms of these processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250171      PMCID: PMC1858006     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Expression of Xist in mouse germ cells correlates with X-chromosome inactivation.

Authors:  J R McCarrey; D D Dilworth
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

2.  Unique expression patterns of H19 in human testicular cancers of different etiology.

Authors:  A J Verkerk; I Ariel; M C Dekker; T Schneider; R J van Gurp; N de Groot; A J Gillis; J W Oosterhuis; A A Hochberg; L H Looijenga
Journal:  Oncogene       Date:  1997-01-09       Impact factor: 9.867

3.  Evidence that random and imprinted Xist expression is controlled by preemptive methylation.

Authors:  D P Norris; D Patel; G F Kay; G D Penny; N Brockdorff; S A Sheardown; S Rastan
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

4.  Developmental changes in methylation of spermatogenesis-specific genes include reprogramming in the epididymis.

Authors:  M Ariel; H Cedar; J McCarrey
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

5.  Xist is expressed in female embryonal carcinoma cells with two active X chromosomes.

Authors:  H H Tai; J Gordon; M W McBurney
Journal:  Somat Cell Mol Genet       Date:  1994-05

6.  Seminomas of the canine testis. Counterpart of spermatocytic seminoma of men?

Authors:  L H Looijenga; R A Olie; I van der Gaag; F J van Sluijs; J Matoska; J Ploem-Zaaijer; C Knepflé; J W Oosterhuis
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

7.  Clonality of combined testicular germ cell tumors of adults.

Authors:  A J Gillis; L H Looijenga; B de Jong; J W Oosterhuis
Journal:  Lab Invest       Date:  1994-12       Impact factor: 5.662

8.  Spermatocytic seminoma: an immunohistochemical study.

Authors:  O W Cummings; T M Ulbright; J N Eble; L M Roth
Journal:  Hum Pathol       Date:  1994-01       Impact factor: 3.466

9.  Expression of the X-inactivation-associated gene XIST during spermatogenesis.

Authors:  E C Salido; P H Yen; T K Mohandas; L J Shapiro
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

10.  X inactivation in mammalian testis is correlated with inactive X-specific transcription.

Authors:  C Richler; H Soreq; J Wahrman
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

View more
  25 in total

1.  Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas.

Authors:  L H Looijenga; A J Gillis; A J Verkerk; W L van Putten; J W Oosterhuis
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation.

Authors:  Fabio Savarese; Katja Flahndorfer; Rudolf Jaenisch; Meinrad Busslinger; Anton Wutz
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

3.  Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types.

Authors:  Carol A Davis-Dao; Kimberly D Siegmund; David J Vandenberg; Eila C Skinner; Gerhard A Coetzee; Duncan C Thomas; Malcolm C Pike; Victoria K Cortessis
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

4.  An up-date on epigenetic and molecular markers in testicular germ cell tumors.

Authors:  Paolo Chieffi
Journal:  Intractable Rare Dis Res       Date:  2017-11

Review 5.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 6.  Expression and function of a large non-coding RNA gene XIST in human cancer.

Authors:  Sarah M Weakley; Hao Wang; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 7.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

8.  X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected.

Authors:  Lisa L Hall; Meg Byron; John Butler; Klaus A Becker; Angel Nelson; Michal Amit; Joseph Itskovitz-Eldor; Janet Stein; Gary Stein; Carol Ware; Jeanne B Lawrence
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

9.  Mutational analysis of proto-oncogene Dbl on Xq27 in testicular germ cell tumors reveals a rare SNP in a patient with bilateral undescended testis.

Authors:  Wan-Hai Xu; Cheng Zhang; Wei-Ming Zhao; Chun-Mei Li; You-Cheng Xiu; Shao-Bin Ni; Ming-Hua Ren; Dian-Jun Sun
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

Review 10.  Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.

Authors:  Silvia Schmidtova; Katarina Kalavska; Lucia Kucerova
Journal:  Curr Oncol Rep       Date:  2018-09-26       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.